ID TNFL8_MOUSE Reviewed; 239 AA. AC P32972; DT 01-OCT-1993, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-1993, sequence version 1. DT 25-JAN-2012, entry version 85. DE RecName: Full=Tumor necrosis factor ligand superfamily member 8; DE AltName: Full=CD30 ligand; DE Short=CD30-L; DE AltName: CD_antigen=CD153; GN Name=Tnfsf8; Synonyms=Cd30l, Cd30lg; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=T-cell; RX MEDLINE=93313964; PubMed=8391931; DOI=10.1016/0092-8674(93)90361-S; RA Smith C.A., Gruess H.-J., Davis T., Anderson D., Farrah T., Baker E., RA Sutherland G.R., Brannan C.I., Copeland N.G., Jenkins N.A., RA Grabstein K.H., Gliniak B., McAlister I.B., Fanslow W., Alderson M., RA Falk B., Gimpsel S., Gillis S., Din W.S., Goodwin R.G., Armitage R.J.; RT "CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose RT ligand defines an emerging family of cytokines with homology to TNF."; RL Cell 73:1349-1360(1993). CC -!- FUNCTION: Cytokine that binds to TNFRSF8/CD30. Induces CC proliferation of T-cells. CC -!- SUBUNIT: Homotrimer (Probable). CC -!- SUBCELLULAR LOCATION: Membrane; Single-pass type II membrane CC protein. CC -!- SIMILARITY: Belongs to the tumor necrosis factor family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; L09754; AAA74595.1; -; mRNA. DR IPI; IPI00113840; -. DR PIR; B40710; B40710. DR RefSeq; NP_033429.1; NM_009403.3. DR UniGene; Mm.4664; -. DR ProteinModelPortal; P32972; -. DR STRING; P32972; -. DR PRIDE; P32972; -. DR Ensembl; ENSMUST00000030047; ENSMUSP00000030047; ENSMUSG00000028362. DR GeneID; 21949; -. DR KEGG; mmu:21949; -. DR CTD; 944; -. DR MGI; MGI:88328; Tnfsf8. DR eggNOG; roNOG10304; -. DR HOGENOM; HBG278304; -. DR HOVERGEN; HBG055267; -. DR InParanoid; P32972; -. DR OMA; WAYLQVS; -. DR OrthoDB; EOG42RD8M; -. DR PhylomeDB; P32972; -. DR NextBio; 301608; -. DR ArrayExpress; P32972; -. DR Bgee; P32972; -. DR Genevestigator; P32972; -. DR GermOnline; ENSMUSG00000028362; Mus musculus. DR GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW. DR GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. DR GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW. DR GO; GO:0005164; F:tumor necrosis factor receptor binding; IEA:InterPro. DR GO; GO:0006955; P:immune response; IEA:InterPro. DR InterPro; IPR006052; TNF. DR InterPro; IPR021185; TNF_CD30_ligand_type. DR InterPro; IPR021184; TNF_CS. DR InterPro; IPR008983; Tumour_necrosis_fac-like. DR Gene3D; G3DSA:2.60.120.40; Tumour_necrosis_fac-like; 1. DR KO; K05471; -. DR Pfam; PF00229; TNF; 1. DR PIRSF; PIRSF019548; TNF_CD30_ligand_type; 1. DR SMART; SM00207; TNF; 1. DR SUPFAM; SSF49842; TNF_like; 1. DR PROSITE; PS00251; TNF_1; 1. DR PROSITE; PS50049; TNF_2; 1. PE 2: Evidence at transcript level; KW Complete proteome; Cytokine; Disulfide bond; Glycoprotein; Membrane; KW Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix. FT CHAIN 1 239 Tumor necrosis factor ligand superfamily FT member 8. FT /FTId=PRO_0000185500. FT TOPO_DOM 1 43 Cytoplasmic (Potential). FT TRANSMEM 44 67 Helical; Signal-anchor for type II FT membrane protein; (Potential). FT TOPO_DOM 68 239 Extracellular (Potential). FT CARBOHYD 75 75 N-linked (GlcNAc...) (Potential). FT CARBOHYD 86 86 N-linked (GlcNAc...) (Potential). FT CARBOHYD 114 114 N-linked (GlcNAc...) (Potential). FT CARBOHYD 158 158 N-linked (GlcNAc...) (Potential). FT CARBOHYD 194 194 N-linked (GlcNAc...) (Potential). FT CARBOHYD 206 206 N-linked (GlcNAc...) (Potential). FT DISULFID 156 182 Potential. SQ SEQUENCE 239 AA; 26519 MW; 29003157DD425159 CRC64; MEPGLQQAGS CGAPSPDPAM QVQPGSVASP WRSTRPWRST SRSYFYLSTT ALVCLVVAVA IILVLVVQKK DSTPNTTEKA PLKGGNCSED LFCTLKSTPS KKSWAYLQVS KHLNNTKLSW NEDGTIHGLI YQDGNLIVQF PGLYFIVCQL QFLVQCSNHS VDLTLQLLIN SKIKKQTLVT VCESGVQSKN IYQNLSQFLL HYLQVNSTIS VRVDNFQYVD TNTFPLDNVL SVFLYSSSD //